Adjuvant Therapy of Nivolumab Combined with Ipilimumab Versus Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
- Creator: Weber, Jeffrey S. , Schadendorf, Dirk , Ascierto, Paolo A. , Sandhu, Shahneen , Eigentler, Thomas , Gutzmer, Ralf , Hassel, Jessica C. , Robert, Caroline , Carlino, Matteo S. , Di Giacomo, Anna Maria , Butler, Marcus O. , Muñoz-Couselo, Eva , Del Vecchio, Michele , Brown, Michael P. , Rutkowski, P , Haydon, A , Grob, J-J , Schachter, J , Queirolo, P , de la Cruz-Merino, L , van der Westhuizen, Andre , Menzies, AM , Re, S , Larkin, James , Bas, T , de Pril, V , Braverman, J , Tenney, DJ , Tang, H , Long, GV , Atkinson, Victoria , Schenker, Michael , Pigozzo, Jacopo , Gogas, Helen , Dalle, Stéphane , Meyer, Nicolas
- Resource Type: journal article
- Date: 2023
Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma
- Creator: Khoja, Leila , Atenafu, Eshetu G. , Ye, Qian , Gedye, Craig , Chappell, Maryanne , Hogg, David , Butler, Marcus O. , Joshua, Anthony M.
- Resource Type: journal article
- Date: 2016